Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMIM10L2B antisense RNA 1 (SMIM10L2B-AS1)
- Target
- SMIM10L2B-AS1
- Molecular classification
- long non-coding RNA (lncRNA), antisense RNA
01
Overview
SMIM10L2B antisense RNA 1 (SMIM10L2B-AS1) is a long non-coding RNA transcribed antisense to the SMIM10L2B gene locus in humans. It belongs to the family of lncRNAs that may regulate gene expression at various levels, including transcriptional and epigenetic mechanisms. There is currently no evidence of it being a drug target, clinical biomarker, or involved in specific disease processes. Its specific function is not characterized, in line with many annotated lncRNAs whose roles remain unclear. Most available information is based on gene annotation databases, with no published evidence for therapeutic targeting, pharmacological interactions, or a defined disease association for SMIM10L2B-AS1 to date. General mechanisms described for antisense and lncRNAs include regulation of gene expression, epigenetic modification, and transcriptional interference.
- Other names
- SMIM10L2B-AS1ENST00000453528HGNC:53137NCBI Gene:100287728Ensembl:ENSG00000228372UniProtKB/TrEMBL:A0ABB0MV24
02
Biological functions
regulation of gene expressionpossible cis-acting and trans-acting effects typical of antisense/lncRNAs
03
Disease associations
none specific; antisense RNAs can play roles in cancer, imprinting disorders, and other conditions, but no evidence for a role of SMIM10L2B-AS1 itself
Beyond the preview
Go deeper on SMIM10L2B antisense RNA 1 (SMIM10L2B-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SMIM10L2B antisense RNA 1 (SMIM10L2B-AS1).